Clinical Trials for DN24-02
1 Open Trial
| Trial Type | Protocol No. & Open Date | Summary |
|---|---|---|
| Therapeutic | VICCURO1187 02/14/2012 | A Randomized, Phase 2, Open-Label Study Evaluating DN24-02 as Adjuvant Therapy in Subjects with High Risk HER2+ Urothelial Carcinoma |
You do not have JavaScript enabled. This site works better with JavaScript turned on.
